Cargando…
AGER promotes proliferation and migration in cervical cancer
The receptor for advanced glycation end products (AGER) is an oncogenic transmembranous receptor up-regulated in various human cancers. We have previously reported that AGER was overexpressed in squamous cervical cancer. However, mechanisms of AGER involved in the progression of cervical cancer are...
Autores principales: | Zhu, Xuejie, Zhou, Lulu, Li, Ruyi, Shen, Qi, Cheng, Huihui, Shen, Zongji, Zhu, Haiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789157/ https://www.ncbi.nlm.nih.gov/pubmed/29298878 http://dx.doi.org/10.1042/BSR20171329 |
Ejemplares similares
-
The Physiology Constant Database of Teen-Agers in Beijing
por: Wei-Qi, Wei, et al.
Publicado: (2004) -
Infelix Ager
por: King, W. G.
Publicado: (1913) -
DYNLT3 overexpression induces apoptosis and inhibits cell growth and migration via inhibition of the Wnt pathway and EMT in cervical cancer
por: Zhang, Jianan, et al.
Publicado: (2022) -
Comments about SuperAging and SuperAgers
por: Goldberg, Terry E.
Publicado: (2019) -
AGER-Mediated Lipid Peroxidation Drives Caspase-11 Inflammasome Activation in Sepsis
por: Chen, Ruochan, et al.
Publicado: (2019)